0000000000947374

AUTHOR

Anna Musciotto

showing 24 related works from this author

STORIA NATURALE DI OSTEONECROSI DA BIFOSFONATI PER OS. A CASE REPORT

2007

researchProduct

Biostimolazione mediante laser a diodi per il trattamento delle osteonecrosi dei mascellari da bifosfonati. Pilot Trial

2007

researchProduct

Halitosis and HCV-related liver disease:true association

2006

researchProduct

Protocol of BRONJ prevention: successful use of antiseptics during oral surgical procedures

2012

Aim: The overall prevention and treatment of Bisphosphonates related osteonecrosis of the jaws (BRONJ) have been the goals of our project structured (labelled PROMaB) within the hospital AOUP “P. Giaccone” (Italy) in order to make better quality life of patients in therapy with amminobisphosphonates (NBP). Material and Methods: Among all procedures, in case of preprogrammed oral surgical procedure, oral antimicrobial rinses (i.e. chlorexidine 0,2% mouthwash and 0,5% gel, three times/day) plus oral systemic antibiotic therapy –e.g. amoxicilin/clavulanate- have been used to reduce the risk of BRONJ in secondary prevention (1 day before and 6 days after). Three hundred and twenty-one patients …

BRONJ prevention antiseptics oral surgerySettore MED/28 - Malattie Odontostomatologiche
researchProduct

Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis

2007

Recently, jawbone osteonecrosis has been largely reported as a potential adverse effect of bisphosphonate (BP) administration. Because of the peculiar pharmacokinetic and pharmacodynamic features of the BF (mainly for i.v. administration), their efficacy and large use, some major issues have to be taken into account extendedly both by oncologists and by dentists: 1) therapeutic dental protocol for patients with diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ); 2) dental strategies for patients in former or current i.v. BF treatment and in absence of BRONJ signs; 3) strategies for patients before i.v. BF treatment. Clinical features and guidelines for the management of th…

medicine.medical_specialtyBone diseasemedicine.medical_treatmentDentistryBone NeoplasmsJaw neoplasmPatient Education as TopicmedicineHumansDental Restoration PermanentIntensive care medicineAdverse effectbisphosphonates metastatic bone diseaseBone Density Conservation AgentsDiphosphonatesbusiness.industrySurrogate endpointAdvanced stageOsteonecrosisHematologyBisphosphonatemedicine.diseaseJaw NeoplasmsOncologybusinessOsteonecrosis of the jawAnnals of Oncology
researchProduct

Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series

2010

Abstract Purpose To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw—a form of jaw osteonecrosis that does not manifest with necrotic bone exposure/mucosal fenestration. Methods Among 332 individuals referred to 5 clinical centers in Europe because of development of jawbone abnormalities after or during exposure to bisphosphonates, we identified a total of 96 patients who presented with the nonexposed variant of osteonecrosis. Relevant data were obtained via clinical notes; radiological investigations; patients' history, and referral letters. Results The most common clinical feature of nonexposed osteonecrosis was jaw bone pa…

OsteochemonecrosisMaleTime FactorsAvascular necrosisMandibleAvascular necrosiEpidemiologyMaxillaProspective cohort studyMultiple myelomaAged 80 and overeducation.field_of_studyAlendronateBone Density Conservation AgentsDiphosphonatesOsteochemonecrosiOsteonecrosisGeneral MedicineBisphosphonatesMiddle AgedKidney NeoplasmsEuropeAvascular necrosisFemaleMultiple MyelomaAdultmedicine.medical_specialtyPopulationJawsBreast NeoplasmsSettore MED/28 - Malattie OdontostomatologicheJawbonesmedicineHumansBisphosphonateeducationAgedBisphosphonate-associated osteonecrosis of the jawbusiness.industryProstatic NeoplasmsAvascular necrosis; Bisphosphonates; Jawbones; Jaws; Mandible; Maxilla; Osteochemonecrosis; Osteonecrosismedicine.diseaseDermatologySurgeryJawMaxillaOsteoporosisJawbonebusinessOsteonecrosis of the jawJaw Diseases
researchProduct

Aging and Oral Health: Effects in Hard and Soft Tissues

2009

Changing demographics, including an increase in life expectancy and the growing numbers of elderly has recently focused attention on the need for geriatric dental care. Ageing affects oral tissues in addition to other parts of the human body, and oral health (including oral mucosa, lips, teeth and associated structures, and their functional activity) is an integral component of general health; indeed, oral disease can cause pain, difficulty in speaking, mastication, swallowing, maintaining a balanced diet, not to mention aesthetical considerations and facial alterations leading to anxiety and depression. The World Health Organization recommends the adoption of certain strategies for improvi…

Palate Hardmedicine.medical_specialtyAgingDentistryOral HealthDental CariesDental Care for AgedQuality of lifeSettore MED/28 - Malattie OdontostomatologicheDrug DiscoveryOral and maxillofacial pathologyMedicineHumansOral mucosaIntensive care medicineaging oral health oral mucosaPharmacologyGeriatricsbusiness.industryMouth MucosaBurning mouth syndromemedicine.diseasestomatognathic diseasesmedicine.anatomical_structureLife expectancyMouth NeoplasmsGeriatric dentistrymedicine.symptomPalate SoftbusinessOral medicine
researchProduct

Halitosis: could it be more than mere bad breath?

2010

Halitosis is a generic term used to describe unpleasant odor emanating from the mouth air and breath, independent of the source where the odor substances originate. It affects between 50 and 65% of the population, but despite its frequency, this problem is often unaccepted and declared as taboo. Ninety percent of patients suffering from halitosis have oral causes: a small, but important percentage, of oral malodor cases have an extra-oral etiology, very often falling into the category of "blood-borne halitosis". Several systemic diseases have been found to provoke malodor or to be a cofactor; bad breath may be an early sign of a serious local or systemic condition. A psychogenic halitosis a…

medicine.medical_specialtyReferralPopulationDentistryOral HealthPrimary careOral hygieneBad breathRisk FactorsSettore MED/28 - Malattie OdontostomatologicheInternal MedicinemedicineHumansPsychogenic diseaseeducationIntensive care medicineHalitosis Bad breathExtra-oral halitosis Intra-oral halitosiseducation.field_of_studySettore MED/12 - Gastroenterologiabusiness.industryHalitosisOral HygieneOdorEmergency MedicineEtiologymedicine.symptomMouth Diseasesbusiness
researchProduct

Findings of osteonecrosis of the jaw under combined bisphosphonate and antiangiogenic therapies: an emergent problem?

2011

antiangiogenic agentsSettore MED/09 - Medicina InternaOsteonecrosis of the jawSettore MED/28 - Malattie OdontostomatologicheSettore BIO/14 - Farmacologiabisphosponate
researchProduct

Nuove prospettive nel Managment dei pazienti con osteonecrosi dei mascellari da bifosfonati

2007

researchProduct

ALITOSI - UPDATE IN TEMA DI EZIOLOGIA E CLINICA

2007

researchProduct

Bifosfonati per osteoporosi e rischio di osteonecrosi dei mascellari: novità in termini di clinica e management

2008

researchProduct

OralChroma vs Halimeter.Accuratezza diagnostica a confronto:studio pilota

2007

researchProduct

ALITOSI ed EPATOPATIE: vera associazione o luogo comune? Studio pilota

2007

researchProduct

Biostimolazione mediante laser a diodi nel trattamento delle osteonecrosi dei mascellari da bifosfonati.

2007

researchProduct

Osteoporosi e Bifosfonati per os:nuova emergenza per l'Odontoiatra

2007

researchProduct

Osteoporosi-malattie dello scheletro e bifosfonati per os: rischio limitato ma emergente di osteonecrosi dei mascellari. Task force (Promab) e propos…

2007

researchProduct

Altosi ed Epatopatie: vera associazione o luogo comune?Studio pilota

2007

researchProduct

L'estetica del sorriso ed il controllo dell'alito

2009

sorriso-alitosi
researchProduct

Osteonecrosi dei mascellari da bifosfonati per os: patologia emergente nel management di osteoporosi e malattie dello scheletro. Ritardo diagnostico …

2007

researchProduct

Il tumore a cellule granulari della lingua in un bambino di 7 anni - case report

2008

researchProduct

Bisphosphonate-associated Osteonecrosis of the jaw: frequencies (82 cases) from the Western Sicily-Promab e ARNAS

2009

Bisphosphonate-Osteonecrosis of the jaw:
researchProduct

Storia naturale di ostenecrosi da bifosfonati per os:A case report

2007

researchProduct

TASK FORCE IN SICILIA OCCIDENTALE PER L’OSTEONECROSI DEI MASCELLARI DA BF E SUA PREVENZIONE I E II: il PROMaB.

2008

researchProduct